|
KAT6B–OPN1LW
(HGNC:17582, HGNC:9936)
|
|
weak |
weak |
weak |
weak |
weak |
|
|
PLA2G15–NFATC3
(HGNC:17163, HGNC:7777)
|
leukemia
(MONDO_0005059)
|
strong |
weak |
strong |
moderate |
weak |
|
|
STARD3–PPP1R1B
(HGNC:17579, HGNC:9287)
|
MONDO:0001056
(MONDO:0001056)
|
strong |
strong |
moderate |
strong |
weak |
|
|
ERC1–RET
(HGNC:17072, HGNC:9967)
|
MONDO:0005075
(MONDO:0005075)
|
strong |
strong |
moderate |
moderate |
weak |
|
|
ARHGAP26–CLDN18
(HGNC:17073, HGNC:2039)
|
MONDO:0004992
(MONDO:0004992)
|
strong |
strong |
moderate |
strong |
weak |
|
|
MEAF6–SUZ12
(HGNC:25674, HGNC:17101)
|
MONDO:0006745
(MONDO:0006745)
|
moderate |
weak |
weak |
moderate |
weak |
|
|
CD74–NRG1
(HGNC:1697, HGNC:7997)
|
lung adenocarcinoma
(MONDO_0005061)
|
strong |
strong |
moderate |
strong |
weak |
|
|
ERC1–FGFR2
(HGNC:17072, HGNC:3689)
|
MONDO:0005061
(MONDO:0005061)
|
strong |
moderate |
moderate |
moderate |
weak |
|
|
HNRNPUL1–MEF2D
(HGNC:17011, HGNC:6997)
|
MONDO:0004967
(MONDO:0004967)
|
strong |
strong |
strong |
moderate |
weak |
|
|
ZMYND11–MBTD1
(HGNC:16966, HGNC:19866)
|
childhood acute myeloid leukemia
(MONDO_0004996)
|
strong |
weak |
moderate |
moderate |
weak |
|
|
SEC31A–ALK
(HGNC:17052, HGNC:427)
|
inflammatory myofibroblastic tumor
(MONDO_0015798)
|
strong |
strong |
moderate |
strong |
weak |
|
|
CEP43–FGFR1
(HGNC:17012, HGNC:3688)
|
acquired polycythemia vera
(MONDO_0009891)
|
moderate |
weak |
moderate |
moderate |
weak |
|
|
MLLT11–KMT2A
(HGNC:16997, HGNC:7132)
|
MONDO:0005059
(MONDO:0005059)
|
strong |
weak |
moderate |
strong |
weak |
|
|
CD28–CTLA4
(HGNC:1653, HGNC:2505)
|
MONDO:0015758
(MONDO:0015758)
|
strong |
strong |
moderate |
strong |
weak |
|
|
FBXW7–NOTCH1
(HGNC:16712, HGNC:7881)
|
T-cell acute lymphoblastic leukemia
(MONDO_0004963)
|
weak |
weak |
weak |
weak |
weak |
|
|
CD47–MET
(HGNC:1682, HGNC:7029)
|
non-small cell lung carcinoma
(MONDO_0005233)
|
strong |
strong |
moderate |
strong |
weak |
|
|
ETV6–ACSL6
(HGNC:3495, HGNC:16496)
|
myeloproliferative neoplasm
(MONDO_0020076)
|
strong |
moderate |
strong |
moderate |
weak |
|
|
CARD11–PIK3R3
(HGNC:16393, HGNC:8981)
|
hematopoietic and lymphoid system neoplasm
(MONDO_0002334)
|
strong |
strong |
moderate |
strong |
weak |
|
|
SLC45A2–AMACR
(HGNC:16472, HGNC:451)
|
liver cancer
(MONDO_0002691)
|
strong |
strong |
moderate |
moderate |
weak |
|
|
TRIM33–RET
(HGNC:16290, HGNC:9967)
|
MONDO:0005192
(MONDO:0005192)
|
moderate |
moderate |
weak |
moderate |
weak |
|